In the News,
Question of The Week,
Alexion Pharmaceuticals, Inc. (NASDAQ: Alxn) Names Francois Nader to Board of Directors
Alexion and Elliott Agree to Collaborate on Identifying a New Board Member
Six CEO Pay Packages That Explain Soaring Executive Compensation
Is Elon Musk's Clash With the SEC a Big Deal for Tesla Stock? It Doesn't Seem That Way.